This is a preview of subscription content, log in via an institution to check access.
References
Cillo C, Cantile M, Faiella A, Boncinelli E . Homeobox genes in normal and malignant cells. J Cell Physiol 2001; 188: 161–169.
Abramovich C, Humphries RK . Hox regulation of normal and leukemic hematopoietic stem cells. Curr Opin Hematol 2005; 12: 210–216.
Strathdee G, Brown R . Aberrant DNA methylation in cancer: potential clinical interventions. Exp Rev Mol Med 2002.
Esteller M . Profiling aberrant DNA methylation in hematologic neoplasms: a view from the tip of the iceberg. Clin Immunol 2003; 109: 80–88.
Herman JG, Baylin SB . Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003; 349: 2042–2054.
Sauvageau G, Lansdorp PM, Eaves CJ, Hogge DE, Dragowska WH, Reid DS et al. Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells. Proc Natl Acad Sci USA 1994; 91: 12223–12227.
Lawrence HJ, Fischbach NA, Largman C . HOX genes: not just myeloid oncogenes any more. Leukemia 2005; 19: 1328–1330.
Toiyama Y, Mizoguchi A, Kimura K, Araki T, Yoshiyama S, Sakaguchi K et al. Persistence of gene expression changes in noninflamed and inflamed colonic mucosa in ulcerative colitis and their presence in colonic carcinoma. World J Gastroenterol 2005; 11: 5151–5155.
Doerksen LF, Bhattacharya A, Kannan P, Pratt D, Tainsky MA . Functional interaction between a RARE and an AP-2 binding site in the regulation of the human HOX A4 gene promoter. Nucleic Acid Res 1996; 24: 2849–2856.
Bijl J, Thompson A, Ramirez-Solis R, Krosl J, Grier DG, Lawrence HJ et al. Analysis of HSC activity and compensatory Hox gene expression profile in Hoxb cluster mutant fetal liver cells. Blood, 8 December 2005 [E-pub ahead of print].
Crooks GM, Fuller J, Petersen D, Izadi P, Malik P, Pattengale PK et al. Constitutive HOXA5 expression inhibits erythropoiesis and increases myelopoiesis from human hematopoietic progenitors. Blood 1999; 94: 519–528.
Lawrence HJ, Christensen J, Fong S, Hu YL, Weissman I, Sauvageau G et al. Loss of expression of the Hoxa-9 homeobox gene impairs the proliferation and repopulating ability of hematopoietic stem cells. Blood 2005; 106: 3988–3994.
So CW, Karsunky H, Wong P, Weissman IL, Cleary ML . Leukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9. Blood 2004; 103: 3192–3199.
Acknowledgements
This work was supported by Cancer Research UK (GS, AS, RB) and by the Leukaemia Research Fund (AP, DO).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Strathdee, G., Sim, A., Parker, A. et al. Promoter hypermethylation silences expression of the HoxA4 gene and correlates with IgVh mutational status in CLL. Leukemia 20, 1326–1329 (2006). https://doi.org/10.1038/sj.leu.2404254
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404254
- Springer Nature Limited
This article is cited by
-
Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLL
Genome Medicine (2020)
-
Genome-wide DNA methylation profiling integrated with gene expression profiling identifies PAX9 as a novel prognostic marker in chronic lymphocytic leukemia
Clinical Epigenetics (2017)
-
Hypomethylation of HOXA4 promoter is common in Silver-Russell syndrome and growth restriction and associates with stature in healthy children
Scientific Reports (2017)
-
450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments
Leukemia (2013)
-
Using cell fate attractors to uncover transcriptional regulation of HL60 neutrophil differentiation
BMC Systems Biology (2009)